SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000793160-10-000006
Filing Date
2010-08-13
Accepted
2010-08-13 15:24:12
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10Q FOR PERIOD ENDED JUNE 30 2010 - MAIN TEXT OF FILING q06302010.txt 10-Q 59542
2 RULE 13A-14(A) OR 15D-14(A) CERTIFICATION OF THE REGISTRANTS PRINCIPAL EXECUTIVE ex311.txt EX-31 4114
3 RULE 13A-14(A) OR 15D-14(A) CERTIFICATION OF THE REGISTRANTS PRINCIPAL FINANCIAL ex312.txt EX-31 4139
4 RULE 13A-14(B) OR 15D-14(B) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIV ex321.txt EX-32 1671
5 RULE 13A-14(B) OR 15D-14(B) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIA ex322.txt EX-32 1712
6 10Q FOR PERIOD ENDED JUNE 30 2010 - COMPLETE WITH EXHIBITS 31 AND 32 q06302010complete.pdf 10-Q 125558
  Complete submission text file 0000793160-10-000006.txt   245827
Mailing Address 9110 RED BRANCH ROAD SUITE J COLUMBIA MD 21045-2024
Business Address 9110 RED BRANCH RD SUITE J COLUMBIA MD 21045-2024 4109972599
IGENE BIOTECHNOLOGY INC (Filer) CIK: 0000793160 (see all company filings)

IRS No.: 521230461 | State of Incorp.: MD | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-15888 | Film No.: 101015075
SIC: 2870 Agricultural Chemicals